These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Safety and tolerability of gabapentin]. Viteri C Rev Neurol; 2002 Feb 1-15; 34(3):292-5. PubMed ID: 12022084 [TBL] [Abstract][Full Text] [Related]
5. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Goa KL; Sorkin EM Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432 [TBL] [Abstract][Full Text] [Related]
7. The absorption of gabapentin following high dose escalation. Berry DJ; Beran RG; Plunkeft MJ; Clarke LA; Hung WT Seizure; 2003 Jan; 12(1):28-36. PubMed ID: 12495646 [TBL] [Abstract][Full Text] [Related]
8. [Gabapentin in children and adolescents with epilepsy]. Herranz JL Rev Neurol; 2002 Feb 16-28; 34(4):384-7. PubMed ID: 12022057 [TBL] [Abstract][Full Text] [Related]
9. Gabapentin in the management of convulsive disorders. McLean MJ Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682 [TBL] [Abstract][Full Text] [Related]
10. [Advantages and disadvantages of new antiepileptic drugs]. Herranz JL Rev Neurol; 1996 Nov; 24(135):1426-34. PubMed ID: 8974750 [TBL] [Abstract][Full Text] [Related]
16. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety. Korn-Merker E; Borusiak P; Boenigk HE Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603 [TBL] [Abstract][Full Text] [Related]
17. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group]. Herranz JL; Sol JM; Hernández G Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239 [TBL] [Abstract][Full Text] [Related]